Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anna-Sophie Schwarze"'
Autor:
Valerie E. Teschner, Ann-Katrin Fleck, Carolin Walter, Anna-Sophie Schwarze, Melanie Eschborn, Timo Wirth, Olga V. Steinberg, Andreas Schulte-Mecklenbeck, I-Na Lu, Marisol Herrera-Rivero, Claudia Janoschka, Jan D. Lünemann, Nicholas Schwab, Gerd Meyer zu Hörste, Julian Varghese, Catharina C. Gross, Refik Pul, Christoph Kleinschnitz, Simone Mader, Edgar Meinl, Monika Stoll, Heinz Wiendl, Luisa Klotz
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background: Cladribine is a highly effective immunotherapy that is applied in two short-term courses over 2 years and reduces relapse rate and disease progression in patients with relapsing multiple sclerosis (MS). Despite the short treatment period,
Externí odkaz:
https://doaj.org/article/620f3b4ae03d47ceb2b1381faa850bb4
Autor:
Claudia Janoschka, Maren Lindner, Nils Koppers, Laura Starost, Marie Liebmann, Melanie Eschborn, Tilman Schneider-Hohendorf, Farina Windener, David Schafflick, Ann-Katrin Fleck, Kathrin Koch, Marie Deffner, Anna-Sophie Schwarze, Andreas Schulte-Mecklenbeck, Imke Metz, Sven G. Meuth, Catharina C. Gross, Gerd Meyer zu Hörste, Nicholas Schwab, Tanja Kuhlmann, Heinz Wiendl, Monika Stoll, Luisa Klotz
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 120(1)
After natalizumab (NAT) cessation, some multiple sclerosis (MS) patients experience a severe disease rebound. The rebound pathophysiology is still unclear; however, it has been linked to interleukin-17-producing T-helper (Th17) cells. We demonstrate